Global Tumor Ablation Market

Tumor Ablation Market Size, Share, Growth Analysis, By Technology(Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation), By Treatment(Surgical Ablation, Laparoscopic Ablation, and Percutaneous Ablation), By Application(Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer), By Product Type(Generators, and Probes/electrodes (Radiofrequency Ablation Probes, Microwave Ablation Probes and Other Probes/Electrodes)), By End Use(Hospitals & Clinics, Cancer Care Centers, Other End Users), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35A2494 | Region: Global | Published Date: September, 2024
Pages: 219 | Tables: 95 | Figures: 76

Tumor Ablation Market Regional Insights

North America is estimated to secure the top spot when it comes to the global tumor ablation market forecast. The presence of a developed healthcare ecosystem, quick adoption of minimally invasive treatment technologies, and high investments in oncology R&D are expected to be key factors promoting the demand for tumor ablation in North America going forward. The United States is estimated to be the leading market for tumor ablation companies in this region owing to high incidence of different types of cancers and rising healthcare expenditure. Canada is also projected to create new opportunities for tumor ablation providers operation in this region. 

Rapid increasing geriatric population and rising preference for minimally invasive treatments are expected to make the Asia Pacific region the fastest expanding market in the world. Growing investments in healthcare research and infrastructure development in countries such as India, China, and Japan are also expected to create a new business scope for tumor ablation providers in the long run. Supportive government initiatives to promote awareness regarding cancer and funding to promote proper cancer treatment are also slated to increase the sales of tumor ablation equipment in this region.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Tumor Ablation Market size was valued at USD 1.48 Billion in 2022 and is poised to grow from USD 1.68 Billion in 2023 to USD 4.63 Billion by 2031, by rising at a CAGR 13.5% during the forecast period (2024-2031).

Tumor ablation providers around the world are estimated to focus on research to maximize their business potential and stay competitive. Developing new therapeutics for specific cancer indications will also be a preferred strategy for new as well as leading tumor ablation companies. Market players can also benefit from government support to take their oncology research capabilities to the next level. Use of advanced drug discovery and development techniques will also be popular among tumor ablation providers in the future.  'Medtronic plc (Ireland) ', 'Boston Scientific Corporation (US) ', 'Johnson & Johnson (Ethicon, Inc.) (US) ', 'AngioDynamics, Inc. (US) ', 'EDAP TMS S.A. (France) ', 'SonaCare Medical, LLC (US) ', 'Merit Medical Systems, Inc. (US) ', 'Misonix, Inc. (US) ', 'HealthTronics, Inc. (US) ', 'Galil Medical Ltd. (US) ', 'IceCure Medical Ltd. (Israel) ', 'Monteris Medical, Inc. (Canada) ', 'Hologic, Inc. (US) ', 'Symple Surgical Inc. (US) ', 'BVM Medical Limited (UK) ', 'Ablatherm (Esaote S.p.A.) (Italy) ', 'Bioventus LLC (US) ', 'CEVOTEC (Germany) ', 'Fujifilm Holdings Corporation (Japan) ', 'InSightec Ltd. (Israel) ', 'Philips Healthcare (Netherlands)'

Prevalence of cancer around the world is increasing at a rapid pace and this is projected to be a key factor driving up the demand for tumor ablation over the coming years. Tumor ablation is used for minimally invasive treatment of liver, lung, and kidney cancers and is especially popular among patients unfit for surgery. 

North America is estimated to secure the top spot when it comes to the global tumor ablation market forecast. The presence of a developed healthcare ecosystem, quick adoption of minimally invasive treatment technologies, and high investments in oncology R&D are expected to be key factors promoting the demand for tumor ablation in North America going forward. The United States is estimated to be the leading market for tumor ablation companies in this region owing to high incidence of different types of cancers and rising healthcare expenditure. Canada is also projected to create new opportunities for tumor ablation providers operation in this region. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Tumor Ablation Market

Report ID: SQMIG35A2494

$5,300
BUY NOW GET FREE SAMPLE